Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1975 2
1977 2
1978 1
1979 2
1980 2
1981 3
1982 6
1983 1
1984 5
1985 2
1986 1
1987 4
1988 6
1989 6
1990 11
1991 3
1992 4
1993 6
1994 9
1995 5
1996 4
1997 1
1998 2
1999 1
2000 1
2002 1
2003 5
2004 3
2005 6
2006 9
2007 7
2008 5
2009 5
2010 5
2011 13
2012 9
2013 7
2014 6
2015 4
2016 7
2017 5
2018 4
2019 4
2020 3
2021 3
2022 3
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

195 results

Results by year

Filters applied: . Clear all
Page 1
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).
European Association for Cardiovascular Prevention & Rehabilitation; Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D; ESC Committee for Practice Guidelines (CPG) 2008-2010 and 2010-2012 Committees. European Association for Cardiovascular Prevention & Rehabilitation, et al. Among authors: alegria e. Eur Heart J. 2011 Jul;32(14):1769-818. doi: 10.1093/eurheartj/ehr158. Epub 2011 Jun 28. Eur Heart J. 2011. PMID: 21712404 Free article.
[ESC/EAS Guidelines for the management of dyslipidaemias].
Reiner Ž, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegría E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs RH, Kjekshus JK, Perrone Filardi P, Riccardi G, Storey RF, David W; Clinical Practice Guidelines Committee of the Spanish Society of Cardiology. Reiner Ž, et al. Among authors: alegria e. Rev Esp Cardiol. 2011 Dec;64(12):1168.e1-1168.e60. doi: 10.1016/j.recesp.2011.09.014. Rev Esp Cardiol. 2011. PMID: 22115524 Free article. Review. Spanish. No abstract available.
[Heart transplant].
Ubilla M, Mastrobuoni S, Martín Arnau A, Cordero A, Alegría E, Gavira JJ, Iribarren MJ, Rodríguez-Fernández T, Herreros J, Rábago G. Ubilla M, et al. Among authors: alegria e. An Sist Sanit Navar. 2006;29 Suppl 2:63-78. An Sist Sanit Navar. 2006. PMID: 16998516 Free article. Review. Spanish.
Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT).
Rossello X, Raposeiras-Roubin S, Latini R, Dominguez-Rodriguez A, Barrabés JA, Sánchez PL, Anguita M, Fernández-Vázquez F, Pascual-Figal D, De la Torre Hernandez JM, Ferraro S, Vetrano A, Pérez-Rivera JA, Prada-Delgado O, Escalera N, Staszewsky L, Pizarro G, Agüero J, Pocock S, Ottani F, Fuster V, Ibáñez B; REBOOT-CNIC investigators. Rossello X, et al. Eur Heart J Cardiovasc Pharmacother. 2022 May 5;8(3):291-301. doi: 10.1093/ehjcvp/pvab060. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 34351426 Clinical Trial.
Update in cardiology: vascular risk and cardiac rehabilitation.
Galve E, Cordero A, Bertomeu-Martínez V, Fácila L, Mazón P, Alegría E, Fernández de Bobadilla J, García-Porrero E, Martínez-Sellés M, González-Juanatey JR. Galve E, et al. Among authors: alegria e. Rev Esp Cardiol (Engl Ed). 2015 Feb;68(2):136-43. doi: 10.1016/j.rec.2014.10.005. Epub 2015 Jan 9. Rev Esp Cardiol (Engl Ed). 2015. PMID: 25583549 Review.
Update in cardiology: vascular risk and cardiac rehabilitation.
Galve E, Alegría E, Cordero A, Fácila L, Fernández de Bobadilla J, Lluís-Ganella C, Mazón P, de Pablo Zarzosa C, González-Juanatey JR. Galve E, et al. Among authors: alegria e. Rev Esp Cardiol (Engl Ed). 2014 Mar;67(3):203-10. doi: 10.1016/j.rec.2013.09.019. Epub 2014 Jan 31. Rev Esp Cardiol (Engl Ed). 2014. PMID: 24774395 Review.
Sex differences and cardiovascular risk.
Cordero A, Alegria E. Cordero A, et al. Among authors: alegria e. Heart. 2006 Feb;92(2):145-6. doi: 10.1136/hrt.2005.069187. Heart. 2006. PMID: 16415182 Free PMC article.
Comments on the ESC guidelines on diabetes, prediabetes, and cardiovascular diseases developed in collaboration with the european society for the study of diabetes.
Task Force of the SEC for the ESC Guidelines on Diabetes, Prediabetes and Cardiovascular Disease; Expert Reviewers for the ESC Guidelines on Diabetes, Prediabetes And Cardiovascular Disease; Guideliness Committee of the SEC. Task Force of the SEC for the ESC Guidelines on Diabetes, Prediabetes and Cardiovascular Disease, et al. Rev Esp Cardiol (Engl Ed). 2014 Feb;67(2):87-93. doi: 10.1016/j.rec.2013.12.003. Epub 2014 Jan 31. Rev Esp Cardiol (Engl Ed). 2014. PMID: 24795114 No abstract available.
195 results